Montelukast should not be given to which age group?

Montelukast, a medication primarily used for the management of asthma and allergic rhinitis, has specific age-related recommendations for its use. In this context, infants younger than 6 months old are generally advised against the use of Montelukast due to safety and efficacy concerns.

In the case of a 4-month-old child, the use of Montelukast is not recommended because this age group has not been adequately studied for safety and potential adverse effects from the medication. More research is needed to establish safe dosing patterns or confirm the drug’s efficacy in very young children. As such, prescribing Montelukast to an infant at this age could result in unforeseen health risks.

Older children and teenagers can typically receive Montelukast as it has been shown to be safe and effective for them, according to prescribing guidelines that allow its use generally in children from ages 2 and up, with prescribing practices continuing for those who are older. Thus, the most accurate answer lies with the young age group of infants, which includes the 4-month-old child in this question.